OPKO HEALTH, INC. (OPK)

1.13 -0.01 (-0.84%)

As of 2026-04-02 18:54:27 EST

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Traded asNasdaq: OPK
ISINUS68375N1037
CIK0000944809
LEI529900A4S2D4OGOJLL02
EIN752402409
Sector—
IndustryPharmaceutical Preparations
CEO—
Employees6,096
Fiscal Year End1231
Address4400 BISCAYNE BLVD., MIAMI, FL, 33137
Phone305-575-4181
Websitehttps://opko.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
OPKOPKO HEALTH, INC.2026-04-02 18:54:271.13-0.01-0.84
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
OPK0000944809OPKO HEALTH, INC.US68375N1037529900A4S2D4OGOJLL02752402409Nasdaq2834Pharmaceutical Preparations1231DE4400 BISCAYNE BLVD.MIAMIFL33137UNITED STATESUS305-575-41814400 BISCAYNE BLVD., MIAMI, FL, 331374400 BISCAYNE BLVD., MIAMI, FL, 33137EXEGENICS INC—1991—6,096https://opko.com539,505,768789,917,433759,067,256OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".2026-04-02 17:30:49
This is a preview of the latest data. Subscribe to access the full data.
OPK Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
OPK Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025539,505,768124,592,24130.0285759,067,25687,516,98613.0321
2024414,913,527-489,569,904-54.127671,550,270-25,441,397-3.6502
2023904,483,431-156,779,292-14.7729696,991,667-75,659,145-9.7922
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Steven D. RubinExecutive Vice President2020810,0000——11,2001,262,200
Adam LogalChief Financial Officer, Senior Vice President2020600,000500,000——11,2001,552,200
Phillip FrostChief Executive Officer2020960,0000——11,2001,538,200
Jane H. HsiaoChief Technical Officer2020900,0000——11,2001,478,200
Jon R. CohenExecutive Chairman, Senior Vice President2020575,0001,150,000——11,2003,491,200
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20252,275
20242,997
20233,930
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue606,879,000713,142,000863,495,000
Cost Of Revenue400,939,000494,632,000445,830,000
Gross Profit205,940,000218,511,000—
Research And Development Expenses124,033,000105,214,00089,593,000
General And Administrative Expenses223,002,000304,220,000300,559,000
Operating Expenses724,288,000865,207,0001,020,516,000
Operating Income-117,409,000-152,065,000-157,021,000
Net Income-225,680,000-53,224,000-188,863,000
Earnings Per Share Basic-0.3-0.08-0.25
Earnings Per Share Diluted-0.30.01—
Weighted Average Shares Outstanding Basic751,132,891694,019,535751,765,915
Weighted Average Shares Outstanding Diluted751,132,891-5,322,400,000—
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents364,409,000426,582,00095,881,000
Marketable Securities Current———
Accounts Receivable90,255,000118,017,000123,379,000
Inventories65,823,00056,797,00065,697,000
Non Trade Receivables———
Other Assets Current8,168,00010,705,0007,673,000
Total Assets Current581,881,000662,089,000309,476,000
Marketable Securities Non Current14,168,00054,584,00016,082,000
Property Plant And Equipment73,926,00070,134,00075,429,000
Other Assets Non Current19,474,00018,537,0009,080,000
Total Assets Non Current1,350,063,0001,538,123,0001,702,222,000
Total Assets1,931,944,0002,200,212,0002,011,698,000
Accounts Payable41,103,00047,071,00069,677,000
Deferred Revenue—6,0000
Short Term Debt10,251,00014,849,00027,293,000
Other Liabilities Current84,406,000118,357,00090,086,000
Total Liabilities Current146,677,000193,096,000200,052,000
Long Term Debt343,966,000437,203,000249,345,000
Other Liabilities Non Current22,799,00032,838,00027,189,000
Total Liabilities Non Current517,308,000641,668,000422,427,000
Total Liabilities663,985,000834,764,000622,479,000
Common Stock7,900,0007,015,0007,820,000
Retained Earnings-2,290,690,000-2,065,010,000-2,011,786,000
Accumulated Other Comprehensive Income-21,017,000-56,130,000-38,030,000
Total Shareholders Equity1,267,959,0001,365,448,0001,389,219,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization91,627,00098,176,000105,297,000
Share Based Compensation Expense10,714,00011,048,00011,413,000
Other Non Cash Income Expense———
Change In Accounts Receivable-30,213,000220,000-3,411,000
Change In Inventories4,118,000-4,217,000-15,197,000
Change In Non Trade Receivables———
Change In Other Assets-23,000-237,000288,000
Change In Accounts Payable-14,217,000-20,662,0002,828,000
Change In Other Liabilities——-11,559,000
Cash From Operating Activities-178,542,000-183,489,000-28,197,000
Purchases Of Marketable Securities—05,000,000
Sales Of Marketable Securities52,182,000166,604,000364,000
Acquisition Of Property Plant And Equipment12,278,00025,010,00016,275,000
Acquisition Of Business—00
Other Investing Activities———
Cash From Investing Activities230,296,000352,214,000-18,198,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends——0
Issuance Of Common Stock———
Repurchase Of Common Stock47,040,00090,223,000—
Issuance Of Long Term Debt0250,000,000—
Repayment Of Long Term Debt41,411,000475,061,000679,709,000
Other Financing Activities———
Cash From Financing Activities-118,056,000184,166,000-11,303,000
Change In Cash-62,873,000349,734,000-57,310,000
Cash At End Of Period364,409,000426,582,00095,881,000
Income Taxes Paid24,463,00010,008,0003,712,000
Interest Paid37,936,00020,883,0008,135,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-0.3-0.08-0.25
Price To Earnings Ratio-4.2-18.375-6.04
Earnings Growth Rate275-68-45.6522
Price Earnings To Growth Ratio-0.01530.27020.1323
Book Value Per Share1.68811.96741.8479
Price To Book Ratio0.74640.74720.8171
Ebitda-109,590,000102,425,000-66,348,000
Enterprise Value936,235,442.661,045,678,716.451,315,923,531.65
Dividend Yield——0
Dividend Payout Ratio——0
Debt To Equity Ratio0.27940.33110.1991
Capital Expenditures95,419,00092,881,000—
Free Cash Flow-273,961,000-276,370,000—
Return On Equity-0.178-0.039-0.1359
One Year Beta0.76821.04311.4131
Three Year Beta0.98131.4161.4548
Five Year Beta1.23151.17911.2302
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
PAGANELLI JOHN ADirector2026-03-2010,000A394,340
UPPALURI SUBBARAO VDirector2026-03-1850,000A50,000
FROST PHILLIP MD ET ALDirector, CEO & Chairman, 10% owner2025-11-21102,371A216,228,819
FROST PHILLIP MD ET ALDirector, CEO & Chairman, 10% owner2025-11-213,894A216,232,713
FROST PHILLIP MD ET ALDirector, CEO & Chairman, 10% owner2025-11-2189,375A216,322,088
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Carlos Curbelo2017-10-03FL26Purchase2017-09-26—$1,001 - $15,000
Carlos Mr Curbelo2017-03-02FL26Purchase2017-03-02—$1,001 - $15,000
Carlos Mr Curbelo2017-02-07FL26Purchase2017-02-07—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
GOLDMAN SACHS GROUP INC2025-12-317,543,5115,986,9131.26
World Investment Advisors2025-12-3183,81666,5201.26
Virtu Financial LLC2025-12-31145,000115,2981.2576
Compound Planning, Inc.2025-12-3114,49011,5001.26
Invesco Ltd.2025-12-31984,907781,6721.26
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Global X Funds2026-01-31Global X Russell 2000 ETFRSSL186,035234,404.10.0169
INVESCO EXCHANGE-TRADED FUND TRUST2026-01-31Invesco RAFI US 1500 Small-Mid ETFPRFZ489,055616,209.30.023
GOLDMAN SACHS TRUST2026-01-31Class P SharesGSXPX1,911,3412,408,289.660.2593
GOLDMAN SACHS TRUST2026-01-31Class R6 SharesGTTUX1,911,3412,408,289.660.2593
GOLDMAN SACHS TRUST2026-01-31Investor SharesGTTTX1,911,3412,408,289.660.2593
This is a preview of the latest data. Subscribe to access the full data.